News

Two med-tech companies focused on pulmonary embolism overcame their own blockages to commercialization this week. Inquis ...
UK regulators on Tuesday fined 23andMe 2.31 million pounds ($3.1 million) for data privacy violations stemming from the ...
Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer protections ultimately led the board’s special committee to select it as ...
The U.K. Information Commissioner’s Office (ICO) has fined U.S.-based 23andMe £2.31 million for serious security failures ...
"There are only a handful of people in the world who have experience in running a direct-to-consumer genetic testing company ...
In a recent investigation we took a hard look at the cybersecurity practices of major direct-to-consumer DNA testing ...
The FTSE 100 faces a stern test of its new high levels this week, with Israel-Iran tensions still running high and Tehran ...
A cyber attack on the genetic testing firm saw personal information of 155,592 UK residents accessed in a major cyber attack in 2023.
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Testing firm 23andMe has been fined more than £2m for failing to protect the sensitive personal and genetic data of more than ...
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
California says the sale of 23andMe to a nonprofit formed by the company's former CEO would skirt a state law specifically ...